U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07550751) titled 'Optimal Dosage of Melatonin for Preoperative Sedation in FESS' on April 11.

Brief Summary: To determine the optimal dosage of Melatonin for preoperative sedation in patients undergoing FESS.

Study Start Date: Aug. 01, 2024

Study Type: INTERVENTIONAL

Condition: Clinical Trial

Intervention: DRUG: Melatonin

comparison between placebo and different melatonin doses(3-5-10 mg)

Recruitment Status: COMPLETED

Sponsor: Aswan University Hospital

Information provided by (Responsible Party): Osaid Abdelshakour Elsayed Abdallah, Aswan University Hospital

Published by HT Digital Content Services with permission from Health Daily Digest...